name: I am confident I can help this person with lifestyle changes, like diet and exercise, even during times of stress:Find:Pt:^Caregiver:Ord:PAM


name: I am confident I can help this person with lifestyle changes, like diet and exercise, even during times of stress


name: Caregiver Patient Activation Measure - 13:-:Pt:^Caregiver:-:PAM


name: Caregiver Patient Activation Measure - 13


name: Caregiver Patient Activation Measure - 10:-:Pt:^Caregiver:-:PAM


name: Caregiver Patient Activation Measure - 10


name: Rotavirus C VP7 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Rotavirus B VP7 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Rotavirus A VP7 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Rotavirus A VP4 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A M gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A HA gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A NA gene:Seq:Pt:Isolate:Nom:Sequencing


name: Arachis hypogaea recombinant (rAra h) 6 Ab.IgE.RAST class


name: Arachis hypogaea recombinant (rAra h) 5 Ab.IgE.RAST class


name: HBA1 & HBA2 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: KIT gene exon 17 targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: KIT gene exon 17 targeted mutation analysis


name: KIT gene exon 13 targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: KIT gene exon 13 targeted mutation analysis


name: KIT gene exon 8 targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: KIT gene exon 8 targeted mutation analysis


name: Intravascular diastolic^post exercise:Pres:Pt:Arterial system:Qn


name: GALC gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GALC gene deletion+duplication & full mutation analysis


name: Intravascular systolic^W exercise:Pres:Pt:Arterial system:Qn


name: Intravascular diastolic^W exercise:Pres:Pt:Arterial system:Qn


name: Intravascular systolic^post exercise:Pres:Pt:Arterial system:Qn


name: Clostridioides difficile BI-NAP1-027 strain DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: BMPR1A & SMAD4 gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: BMPR1A & SMAD4 gene deletion+duplication & full mutation analysis


name: Platelet glycoprotein IV Ab:PrThr:Pt:Ser/Plas:Ord:IA


name: Lifetime risk for developing genetic disease assessed:Likelihood:Lifetime:^Patient:Ord


name: Fibroblast growth factor 21.intact:MCnc:Pt:Ser/Plas:Qn


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen>Hepatic vessels:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Aortic valve:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Abdomen>Abdominal veins & Pelvis>Pelvis veins:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Pulmonary veins:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Coronary arteries+Pulmonary arteries:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Coronary arteries+Aorta.thoracic:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Coronary arteries+Pulmonary arteries+Aorta.thoracic:Doc:CT.angio


name: Multisection:Find:Pt:Pelvis>Pelvis veins & Lower extremity.bilateral>Lower extremity veins:Doc:CT.angio


name: Multisection:Find:Pt:Lower extremity>Lower extremity vessels:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen>Renal vessels:Doc:CT.angio


name: Multisection^WO contrast && Multisection^W contrast IV:Find:Pt:Chest & Chest>Coronary arteries:Doc:CT && CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen>Mesenteric vessels:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen+Pelvis && Abdomen>Aorta.abdominal:Doc:CT && CT.angio


name: Multisection^W contrast IV:Find:Pt:Abdomen+Pelvis && Abdomen>Aorta.abdominal:Doc:CT && CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Head+Neck>Circle of Willis+Carotid arteries:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Head+Neck>Circle of Willis+Carotid arteries:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Abdomen+Pelvis>Deep inferior epigastric artery:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Aorta.thoracic:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal:Doc:CT


name: Multisection^WO contrast && Multisection^W contrast IV:Find:Pt:Abdomen && Abdomen+Pelvis:Doc:CT


name: Multisection^WO contrast && Multisection^W contrast IV:Find:Pt:Abdomen && Chest+Abdomen:Doc:CT


name: Multisection^WO contrast && Multisection^W contrast IV:Find:Pt:Abdomen && Chest+Abdomen+Pelvis:Doc:CT


name: Multisection^WO contrast && Multisection^W contrast IV:Find:Pt:Abdomen+Pelvis && Chest+Abdomen+Pelvis:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen>Kidney & Abdomen+Pelvis>Ureter & Pelvis>Urinary bladder:Doc:CT


name: Multisection by reconstruction^WO & W contrast IV:Find:Pt:Abdomen>Spine.lumbar:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Lung parenchyma:Doc:CT


name: Multisection^W contrast IS:Find:Pt:Lower extremity.bilateral>Knee:Doc:CT


name: Multisection^WO contrast:Find:Pt:Lower extremity.bilateral>Lower leg:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral>Thigh:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral:Doc:CT


name: Multisection^W contrast IS:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:CT


name: Multisection^WO contrast:Find:Pt:Upper extremity.bilateral>Upper arm:Doc:CT


name: Multisection^W Contrast IV:Find:Pt:Upper extremity.left>Finger.fourth:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Head & Head>Pituitary+Sella turcica:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Temporal bone.bilateral:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Head>Temporal bone.bilateral:Doc:CT


name: Guidance for localization of tumor^W 18F-FDG IV:Find:Pt:Head+Neck:Doc:PT+CT


name: Multisection^W contrast IV:Find:Pt:Head>Maxillofacial region.right:Doc:CT


name: Multisection for amyloidosis^W radionuclide IV:Find:Pt:Head>Brain:Doc:PT+CT


name: Multisection^W contrast IV:Find:Pt:Head & Head>Maxillofacial region:Doc:CT


name: Multisection^W contrast IS:Find:Pt:Head>Temporomandibular joint:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head & Head>Sinuses:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head & Head>Maxillofacial region:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Pelvis>Pelvis bones:Doc:CT


name: Guidance for localization of tumor^W 18F-FDG IV+W Contrast IV:Find:Pt:Whole body>Skull vertex to mid-thigh:Doc:PT+CT


name: Guidance for injection of cyst:Find:Pt:XXX:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Neck>Parathyroid gland:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Pelvis>Pelvis bones:Doc:CT


name: Multisection^W contrast IT:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic:Doc:CT


name: Chlamydia trachomatis:PrThr:Pt:Tiss:Ord:Organism specific culture


name: Escherichia coli eaeA gene:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Helicobacter pylori:PrThr:Pt:Stool:Ord:Organism specific culture


name: Helicobacter pylori:PrThr:Pt:Tiss:Ord:Organism specific culture


name: Legionella sp:Prid:Pt:Tiss:Nom:Organism specific culture


name: Legionella sp:Prid:Pt:Water:Nom:Organism specific culture


name: Neisseria meningitidis:PrThr:Pt:Thrt:Ord:Organism specific culture


name: Varicella zoster virus DNA:PrThr:Pt:Body fld:Ord:Probe.amp.tar


name: Toxoplasma gondii:PrThr:Pt:Bone mar:Ord:Organism specific culture


name: Leishmania sp:Prid:Pt:Bone mar:Nom:Organism specific culture


name: Leishmania sp:Prid:Pt:Bld:Nom:Organism specific culture


name: Acanthamoeba sp DNA:PrThr:Pt:Contact lens:Ord:Probe.amp.tar


name: Toxoplasma gondii DNA:PrThr:Pt:Bone mar:Ord:Probe.amp.tar


name: Acanthamoeba sp:Prid:Pt:CSF:Nom:Organism specific culture


name: Acanthamoeba sp:Prid:Pt:Contact lens:Nom:Organism specific culture


name: Strongyloides sp:Prid:Pt:Stool:Nom:Organism specific culture


name: Fasciola hepatica Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Observation:Prid:Pt:Dial fld prt:Nom:Gram stain


name: Kanamycin 2.5 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Trisomy 18 risk based on maternal age + Pregnancy associated plasma protein A + Choriogonadotropin + Nuchal translucency:Likelihood:Pt:^Fetus:Qn


name: Objective assessment of cardiovascular disease:Class:Pt:^Patient:Ord:NYHA


name: How often have you had five or more drinks in one D during the past Y:NRat:1Y:^Patient:Qn:Reported


name: How often have you had five or more drinks in one D during the past Y


name: P super little k Ab:PrThr:Pt:Ser/Plas:Ord


name: P super little k Ab:PrThr:Pt:Ser/Plas^BPU:Ord


name: P super little k Ab:PrThr:Pt:Ser/Plas^Donor:Ord


name: P super little k Ag:PrThr:Pt:RBC^BPU:Ord


name: P super little k Ag:PrThr:Pt:RBC^Donor:Ord


name: Cells.CD4-CD8-CD45R+TCR alpha beta+/Cells.CD3:NFr:Pt:Bld:Qn:Flow cytometry


name: Cells.CD4-CD8-CD45R+TCR alpha beta+:NCnc:Pt:Bld:Qn:Flow cytometry


name: Aquaporin 4 water channel Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: Porcine epidemic diarrhea virus S1 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Person completing form title:Type:Pt:Provider:Nom


name: Initial case report processing information:Find:Pt:Report:Doc


name: Reportable condition response description.brief:Find:Pt:^Patient:Nar


name: Reportable condition response description.brief


name: Reportable condition response information and summary:Find:Pt:^Patient:Doc


name: Reportable condition response information and summary


name: Reportability response report:Find:Pt:{Setting}:Doc:Public health


name: Age range for infant less than 1Mo old:Find:Pt:^Patient:Nom


name: Estimated body mass index greater than 40:Find:Pt:^Patient:Ord


name: Known bacterial drug resistant infection:Find:Pt:^Patient:Ord


name: First degree burn area/Body surface area:ArArea:Pt:^Patient:Qn:Estimated


name: First degree burn area/Body surface area


name: Second degree burn area/Body surface area:ArArea:Pt:^Patient:Qn:Estimated


name: Second degree burn area/Body surface area


name: Third degree burn area/Body surface area:ArArea:Pt:^Patient:Qn:Estimated


name: Third degree burn area/Body surface area


name: Fourth degree burn area/Body surface area:ArArea:Pt:^Patient:Qn:Estimated


name: Fourth degree burn area/Body surface area


name: Cardiopulmonary resuscitation stop time:ClockTime:Pt:^Patient:Qn


name: Cardiopulmonary resuscitation was being given on arrival at destination:Find:Pt:^Patient:Ord


name: Symptoms present for at least 24H:Find:Pt:^Patient:Ord:Reported


name: Gentamicin^random post extended interval dosing:SCnc:Pt:Ser/Plas:Qn


name: Aspartate aminotransferase:CCnc:Pt:Ser/Plas:Qn:No addition of P-5'-P


name: Escherichia coli gene panel:-:Pt:XXX:-:Probe.amp.tar


name: Within the past 12Mo we worried whether our food would run out before we got money to buy more:Find:12Mo:^Patient:Ord


name: Within the past 12Mo the food we bought just didn't last and we didn't have money to get more:Find:12Mo:^Patient:Ord


name: Escherichia coli enterotoxigenic gene panel:-:Pt:XXX:-:Probe.amp.tar


name: Escherichia coli enterotoxigenic gene panel


name: Herpes simplex virus:Prid:Pt:Cornea/Conjunctiva:Nom:Organism specific culture


name: Herpes simplex virus 1 DNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Herpes simplex virus 2 DNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Varicella zoster virus DNA:PrThr:Pt:Ocular fld:Ord:Probe.amp.tar


name: Varicella zoster virus:PrThr:Pt:Cornea/Conjunctiva:Ord:Organism specific culture


name: Varicella zoster virus:PrThr:Pt:Ocular fld:Ord:Organism specific culture


name: Herpes simplex virus DNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Tropheryma whipplei DNA:PrThr:Pt:Ocular fld:Ord:Probe.amp.tar


name: Observation:Prid:Pt:Periton fld:Nom:Acid fast stain


name: Observation:Prid:Pt:Pericard fld:Nom:Acid fast stain


name: Observation:Prid:Pt:Bone mar:Nom:Acid fast stain


name: Observation:Prid:Pt:Ocular fld:Nom:Acid fast stain


name: Observation:Prid:Pt:Amnio fld:Nom:Acid fast stain


name: Toxoplasma gondii:PrThr:Pt:Ocular fld:Ord:Organism specific culture


name: Acanthamoeba sp:Prid:Pt:Cornea/Conjunctiva:Nom:Organism specific culture


name: Toxoplasma gondii DNA:PrThr:Pt:Ocular fld:Ord:Probe.amp.tar


name: Mycobacterium tuberculosis DNA:PrThr:Pt:Ocular fld:Ord:Probe.amp.tar


name: Mycobacterium sp:Prid:Pt:Cornea/Conjunctiva:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Ocular fld:Nom:Organism specific culture


name: Deprecated Microscopic observation [Presence] in Vomitus by Acid fast stain


name: Observation:PrThr:Pt:Plr fld:Ord:Acid fast stain


name: Wuchereria bancrofti+Brugia malayi Ab.IgG4:PrThr:Pt:Ser:Ord:IA


name: Wuchereria bancrofti+Brugia malayi Ab.IgG3:PrThr:Pt:Ser:Ord:IA


name: Wuchereria bancrofti+Brugia malayi Ab.IgG2:PrThr:Pt:Ser:Ord:IA


name: Wuchereria bancrofti+Brugia malayi Ab.IgG1:PrThr:Pt:Ser:Ord:IA


name: Ebola & Marburg virus RNA panel:-:Pt:Bld:-:Probe.amp.tar


name: Influenza virus A subtype:Prid:Pt:Cornea/Conjunctiva:Nom:Probe.amp.tar


name: Dengue virus 1+2+3+4 RNA:PrThr:Pt:Urine:Ord:Probe.amp.tar


name: Dengue virus 1+2+3+4 RNA:PrThr:Pt:Bld:Ord:Probe.amp.tar


name: Crimean-Congo hemorrhagic fever virus Ab.IgM:PrThr:Pt:Ser:Ord:IA


name: Crimean-Congo hemorrhagic fever virus Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: Crimean-Congo hemorrhagic fever virus RNA:PrThr:Pt:Ser:Ord:Probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Influenza virus B Ag:PrThr:Pt:Tiss:Ord:IF


name: Middle East respiratory syndrome coronavirus RNA:PrThr:Pt:Asp:Ord:Probe.amp.tar


name: Influenza virus:Prid:Pt:Cornea/Conjunctiva:Nom:Organism specific culture


name: Herpes simplex virus 1 Ag:PrThr:Pt:Tiss:Ord:IF


name: Respiratory syncytial virus B RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Dengue virus 1 & 2 & 3 & 4 RNA:Prid:Pt:Ser/Bld:Nom:Probe.amp.tar


name: Respiratory syncytial virus A RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Lymphocytic choriomeningitis virus Ab.IgM:PrThr:Pt:Ser:Ord:IA


name: Lymphocytic choriomeningitis virus Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: Lymphocytic choriomeningitis virus RNA:PrThr:Pt:CSF:Ord:Probe.amp.tar


name: Parainfluenza virus 1 RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Parainfluenza virus 2 RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: Parainfluenza virus 3 RNA:PrThr:Pt:Cornea/Conjunctiva:Ord:Probe.amp.tar


name: HIV 1 proviral DNA:PrThr:Pt:CSF:Ord:Probe.amp.tar


name: Parechovirus RNA:PrThr:Pt:Respiratory system specimen.upper:Ord:Probe.amp.tar


name: Observation:Prid:Pt:Bil fld:Nom:Acid fast stain


name: Observation:PrThr:Pt:Synv fld:Ord:Acid fast stain


name: LCDS v4.00 - Functional abilities and goals - planned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v4.00 - Functional abilities and goals - planned discharge


name: LCDS v4.00 - Functional abilities and goals:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v4.00 - Functional abilities and goals


name: Guidance for infusion of non-thrombolytic:Find:Pt:Head>Head arteries:Doc:{Imaging modality}


name: Guidance for removal of tunneled catheter:Find:Pt:Chest>Pleura:Doc:{Imaging modality}


name: Guidance for removal of tunneled catheter


name: Acinetobacter sp (rpsA) gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial carbapenem resistance blaIMP gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial carbapenem resistance blaKPC gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial carbapenem resistance blaNDM gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial carbapenem resistance blaOXA gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial carbapenem resistance blaVIM gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial cephalosporin resistance blaCTX-M gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial methicillin resistance mecA gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial vancomycin resistance vanA gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Bacterial vancomycin resistance vanB gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Citrobacter sp (ompA+mrkC) genes:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Enterobacter sp (gyrB+metB) genes:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Enterococcus faecalis hsp60 gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Enterococcus faecium hsp60 gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Gram positive bacteria identified:Imp:Pt:Bld.pos growth:Nom:Probe


name: Gram positive blood culture panel:-:Pt:Bld.pos growth:-:Probe


name: Klebsiella oxytoca (ompA) gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Klebsiella pneumoniae yggE gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Listeria sp (tuf) gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Mycobacterium sp rRNA:Prid:Pt:Bld.pos growth:Nom:Probe


name: Proteus sp (atpD) gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Pseudomonas aeruginosa (sodA) gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Staphylococcus aureus gyrB gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Staphylococcus epidermidis hsp60 gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Staphylococcus lugdunensis sodA gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Staphylococcus sp tuf gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Streptococcus agalactiae hsp60 gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Streptococcus anginosus group gyrB gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Streptococcus pneumoniae gryB gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Streptococcus pyogenes hsp60 gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Streptococcus sp tuf gene:PrThr:Pt:Bld.pos growth:Ord:Probe


name: Multisection^WO contrast & Multisection for left ventricular function


name: WO contrast and for left ventricular function W contrast IV


name: Escherichia coli enterotoxigenic heat-labile toxin


name: Inpatient discharge facility within the past 14D


name: Reportable condition response information


name: Kansas City Cardiomyopathy Questionnaire - 12 item


name: Observation unit (unit that provides < 24 hour stays)


name: Telemetry/step-down unit (less acuity than ICU)


name: Other (jail, institutional care, mental health, etc.)


name: Supportive care with no Renal Replacement Therapy (RRT)


name: Indwelling catheter (including suprapubic catheter and nephrostomy tube)


name: Ostomy (including urostomy, ileostomy, and colostomy)


name: Formal assessment instrument/tool (e.g., Braden, Norton, or other)


name: Central venous catheter lumen obstruction


name: Catheter portion only of central venous catheter with port


name: Tunneled central venous catheter without port


name: Non-tunneled central venous catheter without port


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Hailey Fe 1/20 28 Day]


name: FAMCICLOVIR 1 g in 1 g NOT APPLICABLE POWDER


name: Kaolin 45.5 g in 130 g TOPICAL CREAM [SONATURAL THE PURE PORE TENSING CARBONIC BUBBLE POP CLAY MASK]


name: MITOMYCIN 24.75 g in 25 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: {1 (10 ML) (polyethylene glycol 400 0.004 MG/MG / propylene glycol 0.003 MG/MG Ophthalmic Gel) / 1 (10 ML) (polyethylene glycol 400 4 MG/ML / propylene glycol 3 MG/ML Ophthalmic Solution) } Pack


name: AVOBENZONE 30 mg in 1 mL / OCTINOXATE 73 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL / OXYBENZONE 20 mg in 1 mL TOPICAL CREAM [Milani Prime Protect SPF 30 Face Primer]


name: SILICON DIOXIDE 0.88 g in 11 g TOPICAL STICK [SONATURAL ALL KILL BLACKHEAD CLEAR]


name: TITANIUM DIOXIDE 0.1462 g in 1 g / OCTINOXATE 0.067 g in 1 g / OCTISALATE 0.04 g in 1 g TOPICAL CREAM [Lagom CF Cushion 10]


name: ZINC OXIDE 128.8 mg in 1 mL / TITANIUM DIOXIDE 33.7 mg in 1 mL Topical CREAM [No Makeup Foundation Fair Broad Spectrum SPF 30]


name: METHAZOLAMIDE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ZINC OXIDE 59.8 mg in 1 g / TITANIUM DIOXIDE 48.0 mg in 1 g TOPICAL CREAM [No Makeup Concealer Fair Broad Spectrum SPF 35]


name: ZINC OXIDE 128.8 mg in 1 mL / TITANIUM DIOXIDE 33.7 mg in 1 mL Topical CREAM [No Makeup Foundation Fair-Light Broad Spectrum SPF 30]


name: MEPIVACAINE HYDROCHLORIDE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: TITANIUM DIOXIDE 0.1462 g in 1 g / OCTINOXATE 0.067 g in 1 g / OCTISALATE 0.04 g in 1 g TOPICAL CREAM [Lagom CF Cushion 20]


name: ZINC OXIDE 86 mg in 1 g / TITANIUM DIOXIDE 65 mg in 1 g TOPICAL CREAM [Sun Armor SPF 50]


name: ZINC OXIDE 186 mg in 1 g TOPICAL CREAM [SheerZinc SPF 30 Tinted - Nude]


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 20 g in 100 g TOPICAL CREAM [Gillette Clinical Soft Ultimate Fresh]


name: ZINC OXIDE 170 mg in 1 g TOPICAL CREAM [Light Tint Clear Zinc Solar Protection SPF 30]


name: ZINC OXIDE 176.7 mg in 1 g TOPICAL CREAM [Tinted Clear Zinc Solar Protection SPF 30]


name: METAMIZOLE SODIUM .99 kg in 1 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: DECOQUINATE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: IBUTAMOREN MESYLATE 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ZINC OXIDE 186 mg in 1 g TOPICAL CREAM [Broad Spectrum SPF 30 for Face and Body]


name: ZINC OXIDE 85.0 mg in 1 mL / TITANIUM DIOXIDE 65.0 mg in 1 mL TOPICAL CREAM [Cover Recover SPF 30 Beige]


name: ZINC OXIDE 186 mg in 1 g TOPICAL CREAM [Pyratine XR Creme With Sunscreen Broad Spectrum SPF30]


name: ZINC OXIDE 85.0 mg in 1 mL / TITANIUM DIOXIDE 65.0 mg in 1 mL TOPICAL CREAM [Cover Recover SPF 30 Cocoa]


name: LEVOMENOL 0.07 g in 15 mL TOPICAL OIL [PurpleU BAOBAB FACE]


name: Kaolin 4.0 g in 100 g TOPICAL CREAM [Dr Pore Tightening PINK CLAY FACIAL MASK]


name: Kaolin 8.0 g in 100 mL TOPICAL CREAM [Dr Pore Tightening GLACIAL CLAY FACIAL MASK]


name: altrenogest 247.5 g in 250 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ENROFLOXACIN 19.8 kg in 20 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ZINC OXIDE 50.0 mg in 1 mL / TITANIUM DIOXIDE 48.0 mg in 1 mL TOPICAL CREAM [Mineral Sunscreen Moisturizer Broad Spectrum SPF 20]


name: ZINC OXIDE 50.0 mg in 1 mL TOPICAL CREAM [Mineral Sunscreen Broad Spectrum SPF 30]


name: ZINC OXIDE 51.4 mg in 1 mL / TITANIUM DIOXIDE 73.6 mg in 1 mL TOPICAL CREAM [Mineral Sunscreen Broad Spectrum SPF 45]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 45 mg in 1 mL TOPICAL CREAM [Clear Daylight Radiance Moisturizer Broad Spectrum SPF 32]


name: MIRTAZAPINE HEMIHYDRATE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: OCTINOXATE 6 g in 100 mL / ZINC OXIDE 3 g in 100 mL TOPICAL LOTION [Olay Age Defying Classic Daily Renewal Broad Spectrum SPF 15]


name: TIOPRONIN 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: Isocitrate Dehydrogenase 2 Inhibitor [EPC]


name: ZINC OXIDE 55 mg in 1 mL / TITANIUM DIOXIDE 44 mg in 1 mL TOPICAL CREAM [Mineral Foundation SPF 30-3W]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 45 mg in 1 mL TOPICAL CREAM [Light Daylight Tinted Radiance Moisturizer Broad Spectrum SPF 32]


name: SUNFLOWER OIL 7.92 g in 14 g TOPICAL STICK [OrgaPlus Super Care Balm for combination and oi ly skin type 14g]


name: SUNFLOWER OIL 11.31 g in 20 g TOPICAL STICK [OrgaPlus Super Care Balm for combination and oi ly skin type 20g]


name: ERBORIAN DOUBLE SAMPLE CC CREME CLAIR and DORE SPF 25 KIT


name: TACROLIMUS 49.5 g in 50 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: PYRAZINAMIDE 11.88 kg in 12 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: PIROXICAM 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: BUTAFOSFAN 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: CARBIMAZOLE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: HYDROQUINONE 19 mg in 1 g TOPICAL CREAM [SYMBA Skin Lightening]


name: ZINC OXIDE 60 mg in 1 g / TITANIUM DIOXIDE 47 mg in 1 g TOPICAL CREAM [Quench and Protect Hydrating SPF 30]


name: ZINC OXIDE 63 mg in 1 mL / TITANIUM DIOXIDE 23.6 mg in 1 mL TOPICAL LOTION [Youth 1 Activating BB Cream SPF 30 Light]


name: ZINC OXIDE 86 mg in 1 mL / TITANIUM DIOXIDE 65 mg in 1 mL TOPICAL CREAM [Sun Shield SPF 50]


name: OCTINOXATE 60 mg in 1 mL / ZINC OXIDE 45 mg in 1 mL TOPICAL CREAM [EMINENCE Red Currant Protective Moisturizer]


name: ZINC OXIDE 120 mg in 1 mL TOPICAL CREAM [Bio Active Complex SPF 15]


name: ZINC OXIDE 177 mg in 1 mL TOPICAL CREAM [Everyday Sheer Coverage Light Tint SPF 20]


name: ZINC OXIDE 186 mg in 1 g TOPICAL CREAM [Tropical Topical Matte SPF 30]


name: ZINC OXIDE 189 mg in 1 mL TOPICAL CREAM [Natural Protection Face and Eyes SPF 30]


name: AVOBENZONE 15 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL / ECAMSULE 5 mg in 1 mL / TITANIUM DIOXIDE 25 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle SPF 30 Sport Water Resistant]


name: AVOBENZONE 15 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL / ECAMSULE 5 mg in 1 mL / TITANIUM DIOXIDE 33 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle SPF 45 Sport]


name: AVOBENZONE 22.4 mg in 1 mL / DROMETRIZOLE TRISILOXANE 5 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 24 mg in 1 mL / OCTOCRYLENE 44.8 mg in 1 mL / OXYBENZONE 28.8 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle SPF 30 Sport Endurance Water Resistant]


name: chlorhexidine / climbazole / salicyloyl phytosphingosine


name: SODIUM CITRATE 0.76 g in 29 mL / DEXTROSE MONOHYDRATE 0.74 g in 29 mL / CITRIC ACID MONOHYDRATE 94.8 mg in 29 mL / SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE 72.8 mg in 29 mL INTRAVENOUS INJECTION, SOLUTION [Sterile Cord Blood Collection Unit (MSC128D)]


name: Beta-1 adrenergic receptor antagonist (disposition)


name: Anterior pituitary hormone (disposition)


name: Angiotensin II receptor antagonist (disposition)


name: {1 (acetaminophen 32.5 MG/ML / diphenhydramine hydrochloride 1.25 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Solution) } Pack


name: Aspartic proteinase inhibitor (disposition)


name: Benzodiazepine receptor antagonist (disposition)


name: Beta adrenergic receptor antagonist (disposition)


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [VyLibra 28 Day]


name: {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-VyLibra 28 Day]


name: Beta adrenergic receptor agonist (disposition)


name: XIAP, 3-BP DEL, 1045GAG (dbSNP rs199683465)


name: REST, 2-BP DEL, 2865AA (dbSNP SCV000579327)


name: DONSON, SER28ARG, c.786-33A-G (dbSNP rs192585552), AND LYS489THR (dbSNP rs146664036) HAPLOTYPE


name: Angiotensin-converting enzyme inhibitor (disposition)


name: Niacinamide 1.6 g in 80 mL / Adenosine 0.03 g in 80 mL TOPICAL CREAM [LEBODY BU W RENEWAL UP]


name: TITANIUM DIOXIDE 2.099 g in 50 mL / ZINC OXIDE 3.5 g in 50 mL / OCTINOXATE 3.75 g in 50 mL TOPICAL CREAM [MISSHA M Perfect Cover BB Cream SPF42 (No. 25)]


name: Adenosine 0.004 g in 10 mL / Tranexamic acid 0.001 g in 10 mL TOPICAL LIQUID [SKINMD LABORATORIES ReviTox blue]


name: Dimethicone 1.61 g in 50 mL TOPICAL GEL [SKINMD LABORATORIES REVIGE L]


name: Glycerin 15.0 g in 150 mL TOPICAL GEL [LEBODY FACE RENEWAL]


name: Tranexamic acid 0.02 g in 10 mL / Adenosine 0.004 g in 10 mL TOPICAL CREAM [SKINMD LABORATORIES PURE WHITENOL INTENSIVE]


name: Tranexamic acid 0.05 g in 50 mL TOPICAL CREAM [SKINMD LABORATORIES PURE WHITENOL SERUM]


name: TITANIUM DIOXIDE 65 mg in 1 mL / ZINC OXIDE 66.5 mg in 1 mL TOPICAL CREAM [Likewise Facial Moisturizer - Sun Protectant SPF 50 Oily Skin]


name: Titanium Dioxide 4 mg in 100 mL TOPICAL CREAM [Principal Secret Reclaim Oil Control hydrator SPF-8]


name: ALUMINUM CHLOROHYDRATE 18 g in 100 mL TOPICAL LIQUID [Ban Purely Gentle Roll-On Antiperspirant Deodorant Unscented]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 23 mg in 1 mL TOPICAL CREAM [Isa SunGuard SPF 30]


name: AVOBENZONE 20 mg in 1 mL / OCTINOXATE 60 mg in 1 mL / OCTOCRYLENE 27 mg in 1 mL / OXYBENZONE 20 mg in 1 mL TOPICAL CREAM [ReVive Fermitif Neck Renewal SPF 15]


name: HOMOSALATE 9 g in 100 g / AVOBENZONE 2.7 g in 100 g / OCTOCRYLENE 9 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL STICK [BANANA BOAT]


name: OCTINOXATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [Oil-Free Daily Hydration SPF 15]


name: OCTINOXATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [Restorative Day Moisture SPF 15]


name: OCTINOXATE 7.5 g in 100 g / OCTISALATE 2.5 g in 100 g / ZINC OXIDE 7.5 g in 100 g TOPICAL LOTION


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / ZINC OXIDE 111.6 mg in 1 mL TOPICAL CREAM [Likewise Facial Moisturizer - Sun Protectant SPF 50 Normal to Dry Skin]


name: OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 6 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g TOPICAL SPRAY [Banana Boat]


name: insulin aspart, human / insulin degludec


name: Capsicum extract / levomenthol / synthetic camphor


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL STICK [Kiss Therapy SPF 30 Cucumber Melon Lip Balm]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL STICK [Kiss Therapy SPF 30 Strawberry Mint Lip Balm]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL STICK [Kiss Therapy SPF 30 Watermelon Rosemary Lip Balm]


name: HOMOSALATE 10 g in 100 g / OCTOCRYLENE 10 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL STICK [Kiss Therapy SPF 30 Blueberry Lime Lip Balm]


name: OCTINOXATE 7.5 g in 100 mL / OCTISALATE 2.5 g in 100 mL / OCTOCRYLENE 2.5 g in 100 mL / ZINC OXIDE 7 g in 100 mL TOPICAL LOTION [Olay Complete UV365 Daily Moisturizer with Sunscreen Broad Spectrum SPF 30 Sensitive]


name: DRESSING,CUTIMED SILTEC SORBACT 3IN X 3IN #7992900


name: CATHERIZATION SET,INTERMITTENT 16FR BARD #4A5146


name: CATHETER,FOLEY SILICONE 2-WAY 22FR 30ML RUSCH #170630220


name: CATHETER,INTERMITTENT 18FR LOFRIC PRIMO #4101840


name: DRESSING,POLYMEM AG 1.8IN X 1.8IN,FERRIS #1022


name: DRESSING,POLYMEM AG 6.5IN X 7.5IN,FERRIS #1077


name: DRESSING,TEGADERM IV ADVANCED 2.5IN X 2.75IN


name: SET,INFUSION,FLOW REGULATOR,84IN W/DRIP CHAMBER #KS-122-2


name: TRACHEAL SUCTION SET 14FR HALYARD #22109


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 2.75 in 100 mL / OXYBENZONE 5 in 100 mL TOPICAL LOTION [SPF 30 face Moisturizer]


name: Titanium Dioxide 0.7 g in 100 mL / Zinc Oxide 4.75 g in 100 mL TOPICAL LOTION [UNBLEMISH Control Broad Spectrum SPF 20]


name: IMIPENEM 1 kg in 1 kg NOT APPLICABLE POWDER [Imipenem]


name: PANTHENOL 0.162 mg in 27 mL / ALLANTOIN 0.081 mg in 27 mL TOPICAL PATCH [MARINE PURIFYING]


name: MITOMYCIN 4.95 g in 5 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: Mary Kay TimeWise Repair Volu-Firm The Go Set KIT


name: HOMOSALATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 26 mg in 1 mL TOPICAL LOTION [NIA 24 SPF 30]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 30 mg in 1 mL / OXYBENZONE 30 mg in 1 mL / TITANIUM DIOXIDE 4 mg in 1 mL TOPICAL CREAM [De-Aging Moisturizing Day Creme With Sunscreen SPF 20]


name: TITANIUM DIOXIDE 100 mg in 1 mL / ZINC OXIDE 80 mg in 1 mL TOPICAL CREAM [Triple Protection Sunscreen Broad Spectrum SPF 30]


name: Titanium Dioxide 2.61 g in 18 g / Octocrylene 1.80 g in 18 g / Homosalate 1.80 g in 18 g / Octisalate 0.90 g in 18 g / Avobenzone 0.54 g in 18 g TOPICAL STICK [WKND UNDERWATER SUN TAN]


name: Titanium Dioxide 4.36 g in 18 g / Octocrylene 1.80 g in 18 g / Homosalate 1.80 g in 18 g / Octisalate 0.90 g in 18 g / Avobenzone 0.54 g in 18 g TOPICAL STICK [WKND UNDERWATER SUN WHITE]


name: Zinc Oxide 5.0 g in 50 mL / Titanium Dioxide 4.0 g in 50 mL TOPICAL CREAM [ECO BARRIER NON CHEMICAL SUN]


name: Niacinamide 0.50 g in 25 g / Adenosine 0.01 g in 25 g TOPICAL PATCH [RED GINSENG BRIGHTENING MASK PACK]


name: Niacinamide 0.80 g in 40 g / Adenosine 0.016 g in 40 g TOPICAL PATCH [RED GINSENG VITALIZING HYDROG EL MASK]


name: RANITIDINE HYDROCHLORIDE .99 kg in 1 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: Excedrin PM Triple Action Caplets and Excedrin Tension Headache KIT


name: GLYCERIN 0.5 mg in 1 mL TOPICAL GEL [Glyzigen Single Dose Intimate Gel]


name: PIMOBENDAN 49.5 g in 50 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ZINC OXIDE 24.5 g in 100 g TOPICAL POWDER [Invincible Setting Powder SPF 45 Deep]


name: ceftriaxone and beta-lactamase inhibitor


name: bictegravir / emtricitabine / tenofovir alafenamide


name: cobicistat / darunavir / emtricitabine / tenofovir alafenamide


name: formoterol, glycopyrronium bromide and beclometasone


name: ramipril, amlodipine and hydrochlorothiazide


name: rosuvastatin, amlodipine and perindopril


name: rosuvastatin, perindopril and indapamide


name: vilanterol, umeclidinium bromide and fluticasone furoate


name: Human immunodeficiency virus fusion inhibitor (disposition)


name: cefoperazone and beta-lactamase inhibitor


name: ceftazidime and beta-lactamase inhibitor


name: OCTISALATE 1.75 g in 35 mL / ZINC OXIDE 1.68 g in 35 mL / TITANIUM DIOXIDE 0.8715 g in 35 mL / OCTINOXATE 2.625 g in 35 mL TOPICAL CREAM [Laser Sunscreen 100]


name: AVOBENZONE 10 mg in 1 g / OCTINOXATE 10 mg in 1 g / OCTOCRYLENE 5 mg in 1 g TOPICAL CREAM [Pro-Collagen Marine Broad Spectrum SPF 30]


name: AVOBENZONE 8 mg in 1 g / OCTINOXATE 35 mg in 1 g / OXYBENZONE 5 mg in 1 g TOPICAL CREAM [Laura Mercier Flawless Skin Repair Day Creme Broad Spectrum SPF 15 Sunscreen]


name: DIMETHICONE 2 g in 100 g / OCTINOXATE 6.6 g in 100 g / OCTISALATE 4.4 g in 100 g TOPICAL STICK [Blistex Medicated Berry Balm]


name: DIMETHICONE 2 g in 100 g / OCTINOXATE 6.6 g in 100 g / OCTISALATE 4.4 g in 100 g TOPICAL STICK [Blistex Medicated Lip Balm]


name: DIMETHICONE 2 g in 100 g / OCTINOXATE 6.6 g in 100 g / OCTISALATE 4.4 g in 100 g TOPICAL STICK [Blistex Medicated Mint Balm]


name: orchard grass pollen extract / Timothy grass pollen extract


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 27 mg in 1 mL TOPICAL LOTION [CeraVe Developed with Dermotologists Ultra Light Moisturizing Broad Spectrum SPF 30]


name: TELMISARTAN 247.5 g in 250 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: Hearing Services - Assessments and Evaluations


name: Medical and Surgical Supplies - Miscellaneous Supplies


name: Administrative, Miscellaneous and Investigational


name: Administrative, Miscellaneous and Investigational - Miscellaneous Supplies


name: CMS Hospital Outpatient payment System - Devices


name: Magnetic Resonance Angiography: Trunk and Lower Extremities


name: Transthoracic and Transesophageal Echocardiography


name: Magnetic Resonance Angiography: Spine and Upper Extremities


name: Percutaneous Transcatheter and Transluminal Coronary Procedures


name: Traction Equipment and Orthopedic Devices


name: Wheelchair Accessories: Manual and Power


name: Hospital Services: Observation and Emergency Department


name: Alcohol Substance Abuse Assessment and Intervention


name: Initial Examination for Medicare Enrollment


name: Counselling, Wellness, and Screening Services


name: Temporary Procedures/Professional Services - Miscellaneous Services


name: Federally Qualified Health Center Visits


name: Temporary Procedures/Professional Services - Other Miscellaneous Services


name: Home Health Nursing Visit: Area of Shortage


name: Home Health or Hospice: Skilled Services


name: Rural Health Clinic: Management and Care


name: Ultrasonic and Steroscopic X-ray Guidance


name: Temporary Codes Assigned to DME Regional Carriers - Miscellaneous


name: Prosthetic Procedures - Lower Limb - Replacement Sockets


name: Prosthetic Procedures - Lower Limb - Protective Covers


name: Prosthetic Procedures - Lower Limb - Additions to Ankle and/or Foot


name: Prosthetic Procedures - Prosthetic Socket Insert


name: Prosthetic Procedures - Penile Prosthetics


name: Prosthetic Procedures - Prosthetic Implants


name: Travel Allowance for Specimen Collection


name: Temporary National Codes Established by Private Payers - Other Tests


name: Temporary National Codes Established by Private Payers - Insulins Services


name: Temporary National Codes Established by Private Payers - Imaging


name: Temporary National Codes Established by Private Payers - Miscellaneous Supplies and Services


name: Temporary National Codes Established by Private Payers - Additional Miscellaneous Supplies and Services


name: Temporary National Codes Established by Private Payers - Home Therapy Services


name: Temporary National Codes Established by Private Payers - Other Services and Fees


name: Hearing Services - Miscellaneous Services and Supplies


name: Hearing Services - Assistive Listening Devices


name: Hearing Services - Other Supplies and Miscellaneous Services


name: X-ray taken using computed radiography technology/cassette-based imaging


name: Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area


name: Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area


name: Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes (TB)


name: Medicare diabetes prevention program (mdpp) virtual make-up session


name: Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care


name: Continuous/focused services: for reporting services by clinicians whose expertise is needed for the ongoing management of a chronic disease or a condition that needs to be managed and followed with no planned endpoint to the relationship; reporting clinician service examples include but are not limited to: a rheumatologist taking care of the patient's rheumatoid arthritis longitudinally but not providing general primary care services


name: Episodic/broad services: for reporting services by clinicians who have broad responsibility for the comprehensive needs of the patient that is limited to a defined period and circumstance such as a hospitalization; reporting clinician service examples include but are not limited to the hospitalist's services rendered providing comprehensive and general care to a patient while admitted to the hospital


name: Episodic/focused services: for reporting services by clinicians who provide focused care on particular types of treatment limited to a defined period and circumstance; the patient has a problem, acute or chronic, that will be treated with surgery, radiation, or some other type of generally time-limited intervention; reporting clinician service examples include but are not limited to, the orthopedic surgeon performing a knee replacement and seeing the patient through the postoperative period


name: Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician


name: Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)


name: Wheelchair accessory, lateral thigh or knee support, any type including fixed mounting hardware, each


name: Wheelchair accessory, foot box, any type, includes attachment and mounting hardware, each foot


name: Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month


name: Rural health clinic or federally qualified health center (rhc/fqhc) only, psychiatric collaborative care model (psychiatric cocm), 60 minutes or more of clinical staff time for psychiatric cocm services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm) and including services furnished by a behavioral health care manager and consultation with a psychiatric consultant, per calendar month


name: Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service)


name: Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service)


name: Insertion of non-biodegradable drug delivery implants, 4 or more (services for subdermal rod implant)


name: Removal of non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)


name: Removal with reinsertion, non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)


name: Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes


name: Documentation of patient reason(s) for not prescribing an oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient preference for not receiving anticoagulation)


name: Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab


name: Documentation of medical reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate (e.g., salvage therapy)


name: Documentation of patient reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate


name: Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason) (G9904)


name: Documentation of cha2ds2-vasc risk score of 0 or 1 for men; or 0, 1, or 2 for women


name: Documentation of medical reason for not receiving combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)


name: Documentation of medical reason(s) for prescribing systemic antimicrobials


name: Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, off-the-shelf


name: Gasket or seal, for use with prosthetic socket insert, any type, each


name: External recharging system for battery for use with cochlear implant or auditory osseointegrated device, replacement only, each


name: Auditory osseointegrated device, transducer/actuator, replacement only, each


name: Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only


name: Magnetic resonance imaging of bilateral upper arms with contrast


name: Cellular transport inhibitor (disposition)


name: Cellular transport activator (disposition)


name: Synaptic vesicular amine transporter inhibitor (disposition)


name: Centrally acting acetylcholinesterase inhibitor (disposition)


name: Opioid receptor partial antagonist (disposition)


name: Interleukin 5 receptor antagonist (disposition)


name: CT guided fine needle aspiration biopsy of spleen


name: OCTINOXATE 70 mg in 1 mL TOPICAL LIQUID [Lancome Paris Absolue Bx Makeup Broad Spectrum SPF 18 Sunscreen Absolute Replenishing Radiant Makeup Normal to Dry Skin]


name: SULFATHIAZOLE 495 g in 500 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: camphor / Eucalyptus oil / menthol / peppermint oil


name: OCTINOXATE 7.5 g in 100 g / OXYBENZONE 3.5 g in 100 g / HOMOSALATE 3 g in 100 g / AVOBENZONE 2.5 g in 100 g TOPICAL CREAM


name: TITANIUM DIOXIDE 5 g in 100 g TOPICAL LOTION


name: OCTOCRYLENE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OXYBENZONE 60 mg in 1 mL TOPICAL LOTION [CVS Health SPF 70 Sun]


name: Niacinamide 0.2 g in 10 mL / Adenosine 0.004 g in 10 mL TOPICAL LIQUID [CellStin Ampoule Black]


name: Niacinamide 0.2 g in 10 mL / Adenosine 0.004 g in 10 mL TOPICAL LIQUID [CellStin Micro Ampoule White]


name: FAMCICLOVIR 247.5 g in 250 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: Niacinamide 0.12 g in 6 mL / Adenosine 0.002 g in 6 mL TOPICAL LIQUID [Ultra V IDEBENONE AMPOULE]


name: Niacinamide 0.5 g in 25 mL TOPICAL PATCH [Ultra V AQUA SHINE MASK]


name: Niacinamide 1.0 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [Ultra V IDEBANONE]


name: Niacinamide 1.0 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [Ultra V IDEBENONE NUTRITIONAL]


name: ALUMINUM CHLOROHYDRATE 20.2 g in 100 g TOPICAL AEROSOL, SPRAY [Degree]


name: Dimethicone 3.81 g in 50 mL TOPICAL CREAM [Ultra V RENEWDERM PLUS]


name: AMOXICILLIN .792 kg in 1 kg / CLAVULANATE POTASSIUM .198 kg in 1 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: Niacinamide 0.5 g in 25 g / Adenosine 0.01 g in 25 g TOPICAL PATCH [do good Perfecting Aqua Mask 5ea]


name: Niacinamide 1.0 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL GEL [do good Perfecting Aqua Ge l Moisturizer]


name: CATHETER,FOLEY 3-WAY 18FR 30ML BARD #1857SI18


name: METRONIDAZOLE BENZOATE 24.75 kg in 25 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: DIAZOXIDE 99 g in 100 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios Clear Skin Face Oil Free Dry Touch Broad Spectrum SPF 60 Sunscreen Water Resistant 80 Minutes]


name: VITAMIN A 0.57 g in 19 g TOPICAL PATCH [C-Mask Pack]


name: camphor / Eucalyptus oil / peppermint oil


name: OCTINOXATE 7.4 g in 100 g / HOMOSALATE 6.2 g in 100 g / OCTISALATE 5 g in 100 g / OXYBENZONE 3.1 g in 100 g / AVOBENZONE 1.5 g in 100 g TOPICAL CREAM [Nova Bright Skin SPF 30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL CREAM [A PERFECT WORLD SPF 40 AGE DEFENSE BROAD SPECTRUM MOISTURIZER WITH WHITE TEA]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 30 mg in 1 g / OXYBENZONE 30 mg in 1 g / zinc oxide 40 mg in 1 g TOPICAL LOTION [Total Sun Protection]


name: NIACINAMIDE 0.46 g in 23 g / ADENOSINE 0.0092 g in 23 g TOPICAL PATCH [CELDERMA Crystal Skin Mask]


name: DEMECARIUM BROMIDE 10 g in 10 g NOT APPLICABLE POWDER


name: Niacinamide 1.00 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [do good Pure Repair Centella]


name: Niacinamide 3.00 g in 150 mL / Adenosine 0.06 g in 150 mL TOPICAL LIQUID [do good Deep Aqua Treatment Toner]


name: AVOBENZONE 1.77 g in 59 mL / OCTINOXATE 4.425 g in 59 mL / OXYBENZONE 2.95 g in 59 mL TOPICAL LOTION [Mario Badescu The Moisture Magnet SPF 15]


name: United States Military Warrant Officer W2


name: Medication Reference Terminology (source)


name: Pharmaceutical and Biological Preparations


name: Preparations by FDA Established Pharmacologic Class


name: Growth Hormone Secretagogue Receptor Agonist [EPC]


name: Terminology Extensions for Classification


name: Lugano Lymphoma Response Classification No Response/Stable Disease by CT


name: Substance with antischistosomal mechanism of action


name: Northside Hospital Amenity Kit--GI Dept KIT


name: rheumatoid factor titer in serum (lab test)


name: Imvexxy 10 MCG includes Starter and Maintenance Packs


name: TaperDex 1.5 MG includes 6 & 12 Day Taper Packs


name: {21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Kelnor 1/50 28 Day]


name: Perioperative Nursing Data Set (code system)


name: Protein C in Platelet poor plasma (lab test)


name: Radionuclide imaging of liver using radioactive isotope


name: Office Staff Made Time for Your Concerns Question


name: Medical Team Made Time for Your Concerns


name: Estrogen receptor modulator (disposition)


name: Serotonin reuptake inhibitor (disposition)


name: ADAM Metallopeptidase Domain 8 Measurement


name: Dopamine reuptake inhibitor (disposition)


name: {24 (Acetaminophen 160 MG Chewable Tablet [Tylenol]) / 1 (120 ML) (Acetaminophen 32 MG/ML Oral Suspension [Tylenol]) } Pack [Tylenol be Ready Kit]


name: {28 (tolvaptan 30 MG Oral Tablet) / 28 (tolvaptan 60 MG Oral Tablet) } Pack


name: {28 (tolvaptan 15 MG Oral Tablet) / 28 (tolvaptan 45 MG Oral Tablet) } Pack


name: {28 (tolvaptan 30 MG Oral Tablet) / 28 (tolvaptan 90 MG Oral Tablet) } Pack


name: {21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Zumandimine 28 Day]


name: {1 (ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG / sodium ascorbate 48110 MG / sodium chloride 3200 MG Powder for Oral Solution) / 1 (polyethylene glycol 3350 100000 MG / potassium chloride 1000 MG / sodium chloride 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution) } Pack [Plenvu]


name: {1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule) } Pack


name: Chemokine (C-X-C Motif) Ligand 13 Measurement


name: Interleukin 2 Receptor Subunit Beta Measurement


name: Lugano Lymphoma Response Classification Partial Remission by CT


name: {28 (tolvaptan 30 MG Oral Tablet [Jynarque]) / 28 (tolvaptan 90 MG Oral Tablet [Jynarque]) } Pack [Jynarque 90/30 Carton]


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Tulana 28 Day]


name: {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Jaimiess 91 Day]


name: {21 (desogestrel 0.15 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 5 (ethinyl estradiol 0.01 MG Oral Tablet) / 2 (inert ingredients 1 MG Oral Tablet) } Pack [Volnea 28 Day]


name: Chemokine (C-C Motif) Ligand 21 Measurement


name: Associated Persons Subject Characteristics Domain


name: IgG Clearance to Albumin Clearance Ratio Measurement


name: Mesothelial Cells to Leukocytes Ratio Measurement


name: Interleukin 2 Receptor Subunit Alpha Measurement


name: {7 (lamotrigine 100 MG Oral Tablet [Subvenite]) / 42 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Orange (for Patients Not Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Valproate)]


name: {14 (lamotrigine 100 MG Oral Tablet [Subvenite]) / 84 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Green (for Patients Taking Carbamazepine, Phenytoin, Phenobarbital, or Primidone and Not Taking Valproate)]


name: {35 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Blue (for Patients Taking Valproate)]


name: Powder for conventional release solution for infusion (dose form)


name: Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease


name: Immunoglobulin G to Albumin Ratio Measurement


name: Phosphatidylcholine to Albumin Ratio Measurement


name: Platelet Factor 4-Heparin Complex Induced Antibody Measurement


name: Interleukin 1 Receptor-Like 1 Measurement


name: Neurofilament Light Chain Protein Measurement


name: Tissue Transglutaminase IgA Antibody Measurement


name: Lugano Lymphoma Response Classification Progressive Disease by CT


name: Lugano Lymphoma Response Classification Progressive Disease by PET


name: Cocaine Amphetamine-Regulated Transcript Protein Measurement


name: Pyridinoline to Creatinine Ratio Measurement


name: Normal Sperm to Total Sperm Ratio Measurement


name: {28 (tolvaptan 15 MG Oral Tablet [Jynarque]) / 28 (tolvaptan 45 MG Oral Tablet [Jynarque]) } Pack [Jynarque 45/15 Carton]


name: {28 (tolvaptan 30 MG Oral Tablet [Jynarque]) / 28 (tolvaptan 60 MG Oral Tablet [Jynarque]) } Pack [Jynarque 60/30 Carton]


name: Conventional release effervescent oral tablet (dose form)


name: von Willebrand Factor Multimers Measurement


name: Lugano Lymphoma Response Classification Complete Remission by CT


name: Complement C1 Esterase Inhibitor Measurement


name: The Screen for Child Anxiety Related Emotional Disorders


name: Phosphatase and Tensin Homolog Measurement


name: Beta-2 adrenergic receptor agonist (disposition)


name: Beta-3 adrenergic receptor agonist (disposition)


name: Associated Persons Subject Status Domain


name: Breast Cancer Surgeon Made Time for Your Concerns


name: Chemokine (C-X-C Motif) Ligand 3 Measurement


name: Breast Cancer Surgeon Made You Comfortable


name: Shortness of Breath Visual Analogue Scale


name: Multiplexed Opsonophagocytic Killing Assay


name: Malignant Bowel Obstruction Color Code Scale


name: Histamine H3 receptor antagonist (disposition)


name: Simplified Preoperative Assessment for Appendix Tumor Score


name: Isocitrate dehydrogenase-2 inhibitor (disposition)


name: Imidazoline receptor agonist (disposition)


name: Substance with gamma-aminobutyric acid receptor agonist mechanism of action


name: Calcium hydrogen phosphate dihydrate/Total in Stone


name: Calcium oxalate dihydrate/Total in Stone


name: Calcium oxalate monohydrate/Total in Stone


name: Carbonated calcium phosphate/Total in Stone


name: Gamma-aminobutyric acid receptor antagonist (disposition)


name: Lugano Lymphoma Response Classification No Response/Stable Disease by PET


name: Environmental and Social Factors Supplemental Qualifiers Dataset


name: Collection duration of Unspecified specimen


name: Substance with isocitrate dehydrogenase-2 inhibitor mechanism of action (substance)


name: Imvexxy 4 MCG includes Starter and Maintenance Packs


name: Norepinephrine uptake inhibitor (disposition)


name: Nicotinic receptor antagonist (disposition)


name: Substance with adrenergic neurone blocker mechanism of action


name: Adrenergic neurone blocker (disposition)


name: Completely - dosing instruction fragment


name: Vesicular monoamine transporter 2 inhibitor (disposition)


name: Corticotropin releasing hormone antagonist (disposition)


name: Conventional release cutaneous patch (dose form)


name: Substance with receptor activator of nuclear factor kappa-B ligand inhibitor mechanism of action


name: Repeatedly - dosing instruction fragment


name: {30 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 4]


name: {90 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 12]


name: Drugs of abuse 7 and Alcohol and Tricyclics panel - Urine by Screen method


name: Androgen receptor antagonist (disposition)


name: Cytomegalovirus terminase complex inhibitor (disposition)


name: Substance with Cytomegalovirus terminase complex inhibitor mechanism of action


name: How Often Experienced Abdominal Bloating


name: How Often Experienced Abdominal Discomfort


name: Return of spontaneous circulation:Find:Pt:^Patient:Nom


name: Date vaccination indication effective:Date:Pt:^Patient:Qn


name: Device or anatomic structure visible in wound:Type:Pt:Wound:Nom


name: Disease stage score for risk calculation:Score:Pt:^Patient:Ord


name: Evaluation and management of radiation exposure note:Find:Pt:{Setting}:Doc:{Role}


name: Evaluation and management of radiation exposure note


name: Medical equipment or product note:Find:Pt:{Setting}:Doc:{Role}


name: Type of anticoagulant medication used:Type:Pt:^Patient:Nom


name: Heart rate special circumstances:Type:Pt:^Patient:Nom


name: Number of unsuccessful attempts:Num:Pt:^Patient:Qn


name: Oxygen was used for preoxygenation:Find:Pt:^Patient:Nom


name: Patient reported outcome measure score:Score:Pt:^Patient:Ord


name: Performance-based measure score interpretation:Imp:Pt:^Patient:Ord


name: Performance-based measure score interpretation


name: Revised Geneva Score panel:-:Pt:^Patient:-:Geneva.Revised


name: Timing of thrombolytic administration in relation to cardiac arrest:Find:Pt:^Patient:Nom


name: Timing of thrombolytic administration in relation to cardiac arrest


name: Type of blood thinning medication used:Type:Pt:^Patient:Nom


name: Factors related to rescue:Find:Pt:^Patient:Nom


name: Cardiac compression start time:ClockTime:Pt:^Patient:Qn


name: Diagnosis to transplant time duration score for risk calculation:Score:Pt:^Patient:Ord


name: Manual therapy technique used:Prid:Pt:^Patient:Nom


name: PROMIS cognitive function - abilities subset - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: Reason for discontinuing aspirin use:Find:Pt:^Patient:Nom


name: Condition present on admission:Find:Pt:^Patient:Ord


name: Donor-recipient gender combination score for risk calculation:Score:Pt:^Patient:Ord


name: Long-term opioid therapy for pain consent:Find:Pt:{Setting}:Doc:{Role}


name: Long-term opioid therapy for pain consent


name: Permission to receive text messages:Find:Pt:^Patient:Ord


name: Time elapsed since stroke:Find:Pt:^Patient:Ord


name: Time of return of spontaneous circulation:ClockTime:Pt:^Patient:Qn


name: Time of return of spontaneous circulation


name: Rose Dyspnea Scale panel:-:Pt:^Patient:-


name: Enteric coated aspirin tablet:Find:Pt:^Patient:Ord


name: Date of condition abatement:Date:Pt:^Patient:Qn


name: Donor type score for risk calculation:Score:Pt:^Patient:Ord


name: Exercise Vital Sign (EVS):-:Pt:^Patient:-


name: Treated for Chlamydia trachomatis or Neisseria gonorrhoeae in last 3 to 12Mo:Presence or Threshold:12 months:^Patient:Ordinal


name: Date vaccination indication expires:Date:Pt:^Patient:Qn


name: Evaluation and management consent:Find:Pt:{Setting}:Doc:Patient


name: Number of defibrillation shocks given:Num:Pt:^Patient:Qn


name: Procedures, Services, or Supplies modifier:Type:Pt:^Patient:Nom


name: German Interdisciplinary Association of Intensive Care and Emergency Care Medicine - recommended MIND protocol set:-:Pt:{Setting}:-


name: German Interdisciplinary Association of Intensive Care and Emergency Care Medicine - recommended MIND protocol set


name: Person who performed defibrillation:Type:Pt:^Patient:Nom


name: Procedures, Services, or Supplies code:Type:Pt:^Patient:Nom


name: Reason for difficult intubation:Find:Pt:^Patient:Nom


name: Reason rescue operation was canceled:Type:Pt:EMS unit:Nom


name: Type of medication used for stomach upset:Type:Pt:^Patient:Nom


name: Wells pulmonary embolism risk calculator panel:-:Pt:^Patient:-:Wells PE risk


name: Wells pulmonary embolism risk calculator panel


name: Willing to change aspirin dose:Find:Pt:^Patient:Ord


name: Procedures, Services, or Supplies modifier


name: Special circumstances associated observations panel:-:Pt:^Patient:-


name: Special circumstances associated observations panel


name: Type of nonsteroidal anti-inflammatory drugs (NSAIDs) used several times a week:Type:Pt:^Patient:Nom


name: Year aspirin regimen began:Date:Pt:^Patient:Qn


name: Age score for risk calculation:Score:Pt:^Patient:Ord


name: Use of supplemental oxygen:Find:Pt:^Patient:Nom


name: EMS physician responsible for management at scene:Pn:Pt:Provider:Nom


name: Patient reported outcome measure name:ID:Pt:^Patient:Nom


name: Patient reported outcome measure score interpretation:Imp:Pt:^Patient:Ord


name: Patient reported outcome measure score interpretation


name: PROMIS item bank - applied cognition - abilities subset - version 1.0:-:7 days:^Patient:-:PROMIS


name: PROMIS item bank - applied cognition - abilities subset - version 1.0


name: Pulmonary Embolism Rule-out Criteria panel


name: {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack [Lo-Zumandimine 28 Day]


name: Certified first responder was on site when EMS unit arrived:Find:Pt:^Patient:Ord


name: CPR guidance provided by dispatch prior to EMS arrival:PrThr:Pt:^Patient:Ord


name: Laboratory ask at order entry panel:-:Pt:^Patient:-


name: Patient reported outcome measure panel:-:Pt:^Patient:-


name: Prehospital therapeutic hypothermia method:Type:Pt:^Patient:Nom:*


name: Prehospital therapeutic hypothermia method


name: Assessment using Montreal cognitive assessment


name: Octinoxate 3.35 g in 50 mL / Titanium Dioxide 3.22 g in 50 mL / Octisalate 1.25 g in 50 mL TOPICAL CREAM [do good Hydra Healing Color Corrector]


name: Niacinamide 0.5 g in 25 mL / Adenosine 0.01 g in 25 mL TOPICAL LIQUID [do good Pure Repair Centella Essence]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 50 mg in 1 g / ZINC OXIDE 50 mg in 1 g TOPICAL CREAM [Sea Star Sparkle SPF-50 MANGO-TANGO]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 50 mg in 1 g / ZINC OXIDE 50 mg in 1 g TOPICAL CREAM [Sea Star Sparkle SPF-50 PARTY CAKE]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 50 mg in 1 g / ZINC OXIDE 50 mg in 1 g TOPICAL CREAM [Sea Star Sparkle SPF-50 VERY BERRY]


name: OCTINOXATE 75 mg in 1 g / OCTOCRYLENE 70 mg in 1 g / OCTISALATE 40 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL CREAM [Beach Gypsy SPF-30]


name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]


name: DIALYSATE,NXSTAGE PUREFLOW #RFP-404 SOLN


name: DIALYSATE,NXSTAGE PUREFLOW #RFP-406 SOLN


name: BAG,ENTERAL DRAINAGE SET ENFIT #EDS-1000


name: CATHERIZATION SET,INTERMITTENT 16FR C#28029S


name: DRESSING,AQUACEL AG FOAM ADHESIVE 5IN X 5IN #420627


name: DRESSING,AQUACEL AG FOAM ADHESIVE 7IN X 7IN #420628


name: DRESSING,DERMANET AG 6IN X 6IN,DEROYAL #46-DN66


name: DRESSING,SORBION SACHET S 4IN X 4IN DRAINAGE


name: IRRIGATION KIT W/ENFIT PISTON SYRINGE AMSURE #ENK127


name: TRACH STOMA PROTECTOR,FOAM 6CM X 5CM BLOM-SINGER BE6200


name: TRACH STOMA PROTECTOR,FOAM 6CM X 5CM BLOM-SINGER BE6215


name: TRACHEAL SUCTION SET 14FR HALYARD #22108


name: VALVE,ENFIT,LOPEZ ENTERAL,ICU MEDICAL #9000-EF


name: Zinc Gluconate 50 mg ORAL CAPSULE [Horny Rhino 66000]


name: Zinc Gluconate 50 mg ORAL CAPSULE [Mega Rhino 82000]


name: AVOBENZONE 10 mg in 1 g / OCTINOXATE 10 mg in 1 g / OCTOCRYLENE 5 mg in 1 g TOPICAL CREAM [Dynamic Resurfacing SPF 30]


name: Adenosine 0.012 g in 30 mL TOPICAL CREAM [Madeca Rejuvenating Calming Serum]


name: Niacinamide 0.10 g in 5 mL / Adenosine 0.002 g in 5 mL TOPICAL PATCH [Dr JmeeLab Double Complex Smile Zone]


name: Niacinamide 0.50 g in 25 mL / Adenosine 0.01 g in 25 mL TOPICAL PATCH [Dr JmeeLab Double Complex Black Mask]


name: Zinc Gluconate 50 mg ORAL CAPSULE [Big Richard]


name: Zinc Gluconate 50 mg ORAL CAPSULE [Pegasus 21000]


name: ADENOSINE 0.04 g in 10 mL / ALLANTOIN 0.03 g in 10 mL TOPICAL LIQUID [BOTANIC TWENTY HYPERCARE PLUMPING FORMULA]


name: ADENOSINE 0.04 g in 150 mL / NIACINAMIDE 2 g in 150 mL / ALLANTOIN 0.1 g in 150 mL TOPICAL LIQUID [BOTANIC TWENTY RECHARGING TONER]


name: OXYBENZONE 60 mg in 1 g / AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL AEROSOL, SPRAY [CVS Health Sport SPF 100 Clear]


name: CARBIMAZOLE 9.9 g in 10 g NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: DOXYCYCLINE 24.75 kg in 25 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ZINC OXIDE 189 mg in 1 mL TOPICAL CREAM [Protect Broad Spectrum SPF 30]


name: HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL / OCTISALATE 30 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OXYBENZONE 60 mg in 1 mL TOPICAL LOTION [CVS Health SPF 70 Ultra Sheer]


name: Hyaluronate sodium 0.2 g in 1 g TOPICAL [Bionect]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 28 mg in 1 mL TOPICAL CREAM [PLANTSCRIPTION SPF 25 POWER ANTI-AGING oil FREE BROAD SPECTRUM]


name: Octinoxate 1.08 g in 15.5 g / Titanium Dioxide 0.84 g in 15.5 g / Octisalate 0.46 g in 15.5 g TOPICAL POWDER [do good Hydra Healing Tension Pact Light Beige]


name: LAURIC ACID 2.4 mg in 15 mL TOPICAL LIQUID


name: Titanium Dioxide 1.36 g in 15 mL / Octinoxate 1.05 g in 15 mL / Octisalate 0.60 g in 15 mL TOPICAL CREAM [Lamuse Return 2 Blessing Visual Balm]


name: TEGASEROD MALEATE 1 g in 1 g NOT APPLICABLE POWDER


name: ADENOSINE 0.012 g in 30 g / GLYCERIN 6 g in 30 g / NIACINAMIDE 0.6 g in 30 g TOPICAL PATCH [CELDERMA Ninetalks Hydrogel Mask]


name: ADENOSINE 0.012 g in 30 g / NIACINAMIDE 0.6 g in 30 g / GLYCERIN 6 g in 30 g TOPICAL PATCH [CELDERMA Pearl Lace Hydrogel Mask]


name: GLYCERIN 0.94 g in 4.7 g / NIACINAMIDE 0.094 g in 4.7 g / ADENOSINE 0.00188 g in 4.7 g TOPICAL PATCH [CELDERMA Ninetalks Hydrogel Eye Patch]


name: Status of Tumor Eligibility for Definitive Local Therapy Question


name: R-HyperCVAD Alternating with High-dose MTX AraC/Rituximab Regimen


name: Regimen Used to Treat Central Nervous System Neoplasm


name: International Society of Pediatric Oncology Staging System


name: Children's Oncology Group/National Wilms' Tumor Study Group Staging System


name: Immune-related Response Evaluation Criteria In Solid Tumors


name: Satisfaction with How Comfortably Bras Fit Question


name: Satisfaction with Being able to Wear Clothing That is Fitted Question


name: Satisfaction with How You Look in Mirror Unclothed Question


name: How Often Felt Confident in Social Setting Question


name: How Often Felt Emotionally Able to do Things You Want to do Question


name: How Often Felt Emotionally Healthy Question


name: How Often Felt of Equal Worth to Other Women Question


name: How Often Felt Feminine in Your Clothes Question


name: How Often Felt Accepting of Your Body Question


name: How Often Felt Like Other Women Question


name: How Often Experienced Pain in Muscles of Your Chest Question


name: How Often Experienced Difficulty Lifting or Moving Your Arms Question


name: How Often Experienced Difficulty Sleeping Because of Discomfort in Breast Area Question


name: How Often Experienced Tightness in Your Breast Area Question


name: How Often Experienced Nagging Feeling in Your Breast Area Question


name: How Often Experienced Pulling in Your Breast Area Question


name: How Often Experienced Tenderness in Your Breast Area Question


name: How Often Experienced Sharp Pains in Your Breast Area Question


name: How Often Experienced Aching Feeling in Your Breast Area Question


name: How Often Experienced Throbbing Feeling in Your Breast Area Question


name: How Often Experienced Swelling of Arm on Side You Had Breast Surgery Question


name: How Often Feel Confident Sexually Question


name: How Often Feel Sexually Attractive in Your Clothes Question


name: How Often Feel Comfortable or at Ease During Sexual Activity Question


name: How Often Feel Satisfied with Your Sex-Life Question


name: How Often Feel Confident Sexually About How Your Breast Area Looks When Unclothed Question


name: How Often Feel Sexually Attractive When Unclothed Question


name: Breast Cancer Surgeon was Professional Question


name: Breast Cancer Surgeon Gave You Confidence Question


name: Breast Cancer Surgeon Involved You in Decision Making Question


name: Breast Cancer Surgeon was Reassuring Question


name: Breast Cancer Surgeon was Thorough Question


name: Breast Cancer Surgeon Was Easy to Talk to Question


name: Breast Cancer Surgeon Understood what You Wanted Question


name: Breast Cancer Surgeon was Sensitive Question


name: Breast Cancer Surgeon was Available when You had Concerns Question


name: Disease-specific Graded Prognostic Assessment


name: Satisfaction with Shape of Your Reconstructed Breasts When Wearing Bra Question


name: Satisfaction with How Normal You Feel in Your Clothes Question


name: Satisfaction with Size of Your Reconstructed Breasts Question


name: Satisfaction with How Your Breasts Line up in Relation to Each Other Question


name: Satisfaction with Softness of Reconstructed Breasts Question


name: Satisfaction with How Equal in Size Your Breasts are to Each Other Question


name: Satisfaction with How Natural Your Reconstructed Breasts Look Question


name: Satisfaction with How Naturally Your Reconstructed Breasts Sits and Hangs Question


name: Satisfaction with How Your Reconstructed Breasts Feel to Touch Question


name: Satisfaction with How Much Your Reconstructed Breasts Feel Like a Natural Part of Your Body Question


name: Satisfaction with How Closely Matched Your Breasts are to Each Other Question


name: Satisfaction with Amount of Rippling of Your Implants That You Can See Question


name: Satisfaction with Amount of Rippling of Your Implants That you Can Feel Question


name: How Often Experienced Difficulty Sitting up Because Abdominal Muscle Weakness Question


name: How Often Experienced Difficulty Doing Everyday Activities Because of Abdominal Muscle Weakness Question


name: How Often Experienced Abdominal Bulging Question


name: How Often Experienced Tightness in Abdomen Question


name: How Often Experienced Pulling in Abdomen Question


name: Satisfaction with How Your Abdomen Looks When Unclothed Question


name: Satisfaction with Position of Navel Question


name: Satisfaction with Appearance of Abdominal Scars Question


name: Satisfaction with How Natural Your Reconstructed Nipples Look Question


name: Regulatory T-Cell to Effector T-Cell Ratio Measurement


name: Neutrophil to Lymphocyte Ratio Measurement


name: Dose-dense AC Followed by Dose-Dense Paclitaxel Regimen


name: CDISC Clinical Classification VALG Test Name Terminology


name: CDISC Clinical Classification VALG Test Code Terminology


name: CDISC Clinical Classification AJCC v7 Test Name Terminology


name: CDISC Clinical Classification AJCC v7 Test Code Terminology


name: CDISC Functional Test 10-Meter Walk/Run Test Name Terminology


name: CDISC Functional Test 10-Meter Walk/Run Test Code Terminology


name: CDISC Functional Test Rising From Floor Test Name Terminology


name: CDISC Functional Test Rising From Floor Test Code Terminology


name: CDISC Functional Test 4-Stair Descend Test Name Terminology


name: CDISC Functional Test 4-Stair Descend Test Code Terminology


name: CDISC Functional Test 4-Stair Ascend Test Name Terminology


name: CDISC Functional Test 4-Stair Ascend Test Code Terminology


name: CDISC Questionnaire IPAQ Short Last 7 Days Self-administered Format Version Test Name Terminology


name: CDISC Questionnaire IPAQ Short Last 7 Days Self-administered Format Version Test Code Terminology


name: CDISC Questionnaire IPAQ Long Last 7 Days Self-Administered Format Version Test Name Terminology


name: CDISC Questionnaire IPAQ Long Last 7 Days Self-Administered Format Version Test Code Terminology


name: CDISC Questionnaire IPAQ Long Last 7 Days Telephone Format Version Test Name Terminology


name: CDISC Questionnaire IPAQ Long Last 7 Days Telephone Format Version Test Code Terminology


name: CDISC Questionnaire IPAQ Short Last 7 Days Telephone Format Version Test Name Terminology


name: CDISC Questionnaire IPAQ Short Last 7 Days Telephone Format Version Test Code Terminology


name: CDISC Questionnaire DRRI-2 Test Name Terminology


name: CDISC Questionnaire DRRI-2 Test Code Terminology


name: AJCC v7 Clinical Classification Question


name: 10 Meter Walk/Run Functional Test Question


name: Rising From Floor Functional Test Question


name: 4 Stair Descend Functional Test Question


name: IPAQ Short Last 7 Days Self-administered Format Version Questionnaire Question


name: IPAQ Long Last 7 Days Self-Administered Format Version Questionnaire Question


name: IPAQ Long Last 7 Days Telephone Format Version Questionnaire Question


name: IPAQ Short Last 7 Days Telephone Format Version Questionnaire Question


name: Veterans Administration Lung Study Group Clinical Classification


name: International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format


name: International Physical Activity Questionnaire (August 2002) Long Last 7 Days Self-Administered Format


name: International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format


name: International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format


name: Deployment Risk and Resilience Inventory-2 Questionnaire


name: 10-Meter Walk/Run - Time to Walk/Run 10 Meters


name: Rising From Floor - Time to Rise From Floor


name: 4-Stair Descend - Was 4-Stair Descend Performed


name: 4-Stair Ascend - Was 4-Stair Ascend Performed


name: IPAQ Short Last 7 Days Self-administered Format Version - Days Vigorous Physical Activities


name: IPAQ Short Last 7 Days Self-administered Format Version - No Vigorous Physical Activities


name: IPAQ Short Last 7 Days Self-administered Format Version - Vigorous Physical Minutes per Day


name: IPAQ Short Last 7 Days Self-administered Format Version - Time Vigorous Don't Know/Not Sure


name: IPAQ Short Last 7 Days Self-administered Format Version - Days Moderate Physical Activities


name: IPAQ Short Last 7 Days Self-administered Format Version - No Moderate Physical Activities


name: IPAQ Short Last 7 Days Self-administered Format Version - Moderate Physical Minutes per Day


name: IPAQ Short Last 7 Days Self-administered Format Version - Time Moderate Don't Know/Not Sure


name: IPAQ Short Last 7 Days Self-administered Format Version - Days Walk at Least 10 Minutes


name: IPAQ Short Last 7 Days Self-administered Format Version - No Walking


name: IPAQ Short Last 7 Days Self-administered Format Version - Walking Minutes per Day


name: IPAQ Short Last 7 Days Self-administered Format Version - Time Walking Don't Know/Not Sure


name: IPAQ Short Last 7 Days Self-administered Format Version - Sitting Weekday Minutes per Day


name: IPAQ Short Last 7 Days Self-administered Format Version - Time Sitting Don't Know/Not Sure


name: IPAQ Long Last 7 Days Self-Administered Format Version - Currently Have Job or Unpaid Work


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous as Part of Work


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Vigorous Job-related Activity


name: IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Work Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate as Part of Work


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Moderate Job-related Activity


name: IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Work Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk as Part of Your Work


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Job-related Walking


name: IPAQ Long Last 7 Days Self-Administered Format Version - Walking Work Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Travel in a Motor Vehicle


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Traveling in a Motor Vehicle


name: IPAQ Long Last 7 Days Self-Administered Format Version - Traveling Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Bicycle Place to Place


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Bicycling From Place to Place


name: IPAQ Long Last 7 Days Self-Administered Format Version - Bicycle Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk Place to Place


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Walking From Place to Place


name: IPAQ Long Last 7 Days Self-Administered Format Version - Walking Place Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous in the Garden/Yard


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Vigorous Activity Garden/Yard


name: IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Garden Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate in the Garden/Yard


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Moderate Activity Garden/Yard


name: IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Garden Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate Inside Home


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Moderate Activity Inside Home


name: IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Home Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk in Leisure Time


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Walking in Leisure Time


name: IPAQ Long Last 7 Days Self-Administered Format Version - Walking Leisure Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous in Leisure Time


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Vigorous Activity Leisure Time


name: IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Leisure Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate in Leisure Time


name: IPAQ Long Last 7 Days Self-Administered Format Version - No Moderate Activity Leisure Time


name: IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Leisure Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Sitting Weekday Minutes per Day


name: IPAQ Long Last 7 Days Self-Administered Format Version - Sitting Weekend Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Currently Have Job or Unpaid Work


name: IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous as Part of Work


name: IPAQ Long Last 7 Days Telephone Format Version - Vigorous Work Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Vigorous Work Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Vigorous Work Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Days Moderate as Part of Work


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Work Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Work Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Work Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Days Walk as Part of Your Work


name: IPAQ Long Last 7 Days Telephone Format Version - Walking Work Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Walking Work Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Walking Work Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Days Travel in a Motor Vehicle


name: IPAQ Long Last 7 Days Telephone Format Version - Traveling Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Traveling Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Traveling Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Days Bicycle Place to Place


name: IPAQ Long Last 7 Days Telephone Format Version - Bicycle Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Bicycle Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Bicycling Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Days Walk Place to Place


name: IPAQ Long Last 7 Days Telephone Format Version - Walking Place Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Walking Place Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Walking Place Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous in the Garden/Yard


name: IPAQ Long Last 7 Days Telephone Format Version - Vigorous Garden Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Vigorous Garden Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Vigorous Garden Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Days Moderate in the Garden/Yard


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Garden Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Garden Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Garden Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Days Moderate Inside Your Home


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Home Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Home Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Home Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Days Walk in Your Leisure Time


name: IPAQ Long Last 7 Days Telephone Format Version - Walking Leisure Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Walking Leisure Minutes Per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Walking Leisure Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous in Your Leisure Time


name: IPAQ Long Last 7 Days Telephone Format Version - Vigorous Leisure Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Vigorous Leisure Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Vigorous Leisure Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Days Moderate in Your Leisure Time


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Leisure Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Leisure Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Moderate Leisure Minutes per Week


name: IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekday Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekday Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Sitting Minutes per Wednesday


name: IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekend Hr and Min per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekend Minutes per Day


name: IPAQ Long Last 7 Days Telephone Format Version - Sitting Minutes per Saturday


name: IPAQ Short Last 7 Days Telephone Format Version - Days Vigorous Physical Activities


name: IPAQ Short Last 7 Days Telephone Format Version - Vigorous Physical Hr and Min per Day


name: IPAQ Short Last 7 Days Telephone Format Version - Vigorous Physical Minutes per Day


name: IPAQ Short Last 7 Days Telephone Format Version - Total Vigorous Minutes per Week


name: IPAQ Short Last 7 Days Telephone Format Version - Days Moderate Physical Activities


name: IPAQ Short Last 7 Days Telephone Format Version - Moderate Physical Hr and Min per Day


name: IPAQ Short Last 7 Days Telephone Format Version - Moderate Physical Minutes per Day


name: IPAQ Short Last 7 Days Telephone Format Version - Total Moderate Minutes per Week


name: IPAQ Short Last 7 Days Telephone Format Version - Days Walk at Least 10 Minutes


name: IPAQ Short Last 7 Days Telephone Format Version - Walking Hr and Min per Day


name: IPAQ Short Last 7 Days Telephone Format Version - Walking Minutes per Day


name: IPAQ Short Last 7 Days Telephone Format Version - Total Walking Minutes per Week


name: IPAQ Short Last 7 Days Telephone Format Version - Sitting Hr and Min per Weekday


name: IPAQ Short Last 7 Days Telephone Format Version - Sitting Minutes per Weekday


name: IPAQ Short Last 7 Days Telephone Format Version - Total Sitting Minutes on Wednesday


name: DRRI-2 - A: Went Through Divorce/Was Left


name: DRRI-2 - A: Robbed/Had My Home Broken Into


name: DRRI-2 - A: Saw/Heard Physical Fight Parent


name: DRRI-2 - A: Physically Punished by Parent


name: DRRI-2 - A: Unwanted Sex Activity Childhood


name: DRRI-2 - A: Unwanted Sex Activity Adulthood


name: DRRI-2 - A: Experienced Natural Disaster


name: DRRI-2 - A: Someone Close Serious Illness


name: DRRI-2 - A: Lost My Job/Trouble Finding Job


name: DRRI-2 - A: Serious Physical Health Problem


name: DRRI-2 - A: Injured by Person - Childhood


name: DRRI-2 - A: Injured by Person - Adulthood


name: DRRI-2 - B: Got Along Well With My Family


name: DRRI-2 - B: Felt Like I Fit in With Family


name: DRRI-2 - B: Family Knew What I Thought/Felt


name: DRRI-2 - B: Contribution Family Appreciated


name: DRRI-2 - B: Shared Interests With Family


name: DRRI-2 - B: Opinions Were Valued by Family


name: DRRI-2 - B: I Was Affectionate With Family


name: DRRI-2 - B: Played Important Role in Family


name: DRRI-2 - B: Spent My Free Time With Family


name: DRRI-2 - B: I Could Be Myself Around Family


name: DRRI-2 - B: Input Sought Family Decisions


name: DRRI-2 - C: Food Was of Very Poor Quality


name: DRRI-2 - C: Conditions Extremely Unsanitary


name: DRRI-2 - C: I Was Exposed to Awful Smells


name: DRRI-2 - C: I Was Subjected to Loud Noises


name: DRRI-2 - C: Restricted Because Local Custom


name: DRRI-2 - C: Hassle With Heavy/Annoying Gear


name: DRRI-2 - D: Went on Combat Patrols/Missions


name: DRRI-2 - D: Witnessed Someone Unit Wounded


name: DRRI-2 - D: Exposed Hostile Incoming Fire


name: DRRI-2 - D: Vehicle/Part of Convoy Attacked


name: DRRI-2 - D: Witnessed Enemy Wounded/Killed


name: DRRI-2 - D: Injured Combat-Related Incident


name: DRRI-2 - D: Fired My Weapon Enemy Combatant


name: DRRI-2 - D: Think I Wounded/Killed Someone


name: DRRI-2 - D: Participate Hand-to-hand Combat


name: DRRI-2 - D: Search/Disarm Potential Enemy


name: DRRI-2 - E: Saw Refugees Who Had Lost Homes


name: DRRI-2 - E: Observed Homes Been Destroyed


name: DRRI-2 - E: Took Care Injured/Dying People


name: DRRI-2 - E: Saw Combatants Had Been Wounded


name: DRRI-2 - E: Saw Americans Had Been Wounded


name: DRRI-2 - E: Saw Bodies of Dead Americans


name: DRRI-2 - E: Saw Bodies of Dead Civilians


name: DRRI-2 - E: Sight/Sound/Smell Dead Animals


name: DRRI-2 - E: Involved Handling Human Remains


name: DRRI-2 - F: Exposed Government-issued DEET


name: DRRI-2 - F: Exposed to Smoke/Air Pollution


name: DRRI-2 - F: Exposed to Diesel/Fuel on Skin


name: DRRI-2 - F: Exposed to Fumes From Heaters


name: DRRI-2 - F: Exposed to Burning Trash/Feces


name: DRRI-2 - G: Concerned Infectious Disease


name: DRRI-2 - G: Health Might Suffer NBC Agents


name: DRRI-2 - G: Felt in Danger of Being Wounded


name: DRRI-2 - G: Concerned Medicine Make Me Sick


name: DRRI-2 - G: Concerned Encounter Explosive


name: DRRI-2 - G: Concern Rocket/Mortar Would Hit


name: DRRI-2 - G: Thought I Would Never Survive


name: DRRI-2 - G: Concerned Trapped in Crossfire


name: DRRI-2 - H: Confident Ability Use Equipment


name: DRRI-2 - H: Prepared to Deal With Climate


name: DRRI-2 - H: Accurately Informed About Role


name: DRRI-2 - H: Had Enough Gear in Case Attack


name: DRRI-2 - H: Military Duties What I Expected


name: DRRI-2 - H: Taught Me Everything I Needed


name: DRRI-2 - I: Could Count on Family Advice


name: DRRI-2 - I: Relatives Look Out for Family


name: DRRI-2 - I: Relatives Take Care of Finances


name: DRRI-2 - I: Happy Communication From Home


name: DRRI-2 - I: Happy With Support From Home


name: DRRI-2 - I: People at Home Show They Cared


name: DRRI-2 - J: My Unit Was Like Family to Me


name: DRRI-2 - J: People in Unit Were Trustworthy


name: DRRI-2 - J: Fellow Unit Appreciated Efforts


name: DRRI-2 - J: Felt Valued Fellow Unit Members


name: DRRI-2 - J: Unit Interested My Well-being


name: DRRI-2 - J: Unit Interested What I Thought


name: DRRI-2 - J: Felt Like My Efforts Counted


name: DRRI-2 - J: Service Appreciated by Leaders


name: DRRI-2 - J: Could Go to Leaders If Problem


name: DRRI-2 - J: Leaders Interested in Welfare


name: DRRI-2 - J: Felt Valued by Leaders of Unit


name: DRRI-2 - K: Treated in Overly Critical Way


name: DRRI-2 - K: Uncooperative Working With Me


name: DRRI-2 - K: Had to Work Harder Prove Myself


name: DRRI-2 - K: Questioned My Abilities Perform


name: DRRI-2 - K: My Mistakes Worse Than Others


name: DRRI-2 - K: Threatened My Physical Safety


name: DRRI-2 - K: Made Crude Sexual Remarks at Me


name: DRRI-2 - K: Spread Rumors Sexual Activities


name: DRRI-2 - K: Tried to Talk into Sexual Acts


name: DRRI-2 - K: Authority Pressure Unwanted Sex


name: DRRI-2 - K: Offered Reward Take Part in Sex


name: DRRI-2 - K: Touched Sexual Way Against Will


name: DRRI-2 - K: Physically Forced to Have Sex


name: DRRI-2 - L: Effect Deployment Relationship


name: DRRI-2 - L: Missing Out on Children Growth


name: DRRI-2 - L: Missing Family Events at Home


name: DRRI-2 - L: Safety and Well-being of Spouse


name: DRRI-2 - L: Safety and Well-being of Child


name: DRRI-2 - L: Unable to Help Family If Crisis


name: DRRI-2 - L: Inability Manage Family Affairs


name: DRRI-2 - L: Damaging Career Because Deploy


name: DRRI-2 - L: Care Child/Dependents Receiving


name: DRRI-2 - L: Being Cheated on by My Spouse


name: DRRI-2 - L: Family Ability Cope With Stress


name: DRRI-2 - L: Spouse Ability Manage Household


name: DRRI-2 - L: Effect Relationship My Children


name: DRRI-2 - L: My Family Financial Situation


name: DRRI-2 - M: Someone Close Serious Illness


name: DRRI-2 - M: My Family Had Money Problems


name: DRRI-2 - M: Relationship With Spouse Ended


name: DRRI-2 - M: Had Major Conflict With Family


name: DRRI-2 - M: Family Had Difficulty Adjusting


name: DRRI-2 - M: Loved One Things I Disapproved


name: DRRI-2 - M: Fam Dangerous Military Duties


name: DRRI-2 - N: Robbed/Had My Home Broken Into


name: DRRI-2 - N: Went Through Divorce/Was Left


name: DRRI-2 - N: Experienced Natural Disaster


name: DRRI-2 - N: Someone Close Serious Illness


name: DRRI-2 - N: Lost My Job/Trouble Finding Job


name: DRRI-2 - N: Serious Physical Health Problem


name: DRRI-2 - N: Someone Close to Me Has Died


name: DRRI-2 - O: Family Make Me Better When Down


name: DRRI-2 - O: Go to Family When Need Advice


name: DRRI-2 - O: I Can Talk About My Deployment


name: DRRI-2 - O: Someone Would Help With Tasks


name: DRRI-2 - O: When Ill Family Will Help Out


name: DRRI-2 - P: Input Sought Family Decisions


name: DRRI-2 - P: Feel Like I Fit in With Family


name: DRRI-2 - P: Family Know What I Think/Feel


name: DRRI-2 - P: Contribution Family Appreciated


name: DRRI-2 - P: I am Affectionate With Family


name: DRRI-2 - P: Play Important Role in Family


name: DRRI-2 - P: Spend My Free Time With Family


name: DRRI-2 - P: I Get Along Well With My Family


name: CDISC SDTM Arm Null Reason Response Terminology


name: CDISC SDTM Vaccines Findings About Test Code Terminology


name: CDISC SDTM Vaccines Findings About Test Name Terminology


name: CDISC Protocol Entities Clinical Study Attribute Terminology


name: PGI Generic Modification Version - Overall Health


name: Streptococcus pneumoniae IgG Antibody Measurement


name: Continuous Audio Recording Made Indicator


name: Streptococcus pneumoniae Serotype 1 IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 2 IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 3 IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 4 IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 5 IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 6B IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 7F IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 8 IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 9N IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 9V IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 10A IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 11A IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 12F IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 14 IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 15B IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 17F IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 18C IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 19F IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 19A IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 20 IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 22F IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 23F IgG Antibody Measurement


name: Streptococcus pneumoniae Serotype 33F IgG Antibody Measurement


name: Cocaine, Benzoylecgonine, and/or Ecgonine Measurement


name: Globulin to Creatinine Ratio Measurement


name: Beta-1 Globulin to Total Beta Protein Ratio Measurement


name: HIV-1 and HIV-2 Antibodies and HIV p24 Antigen Measurement


name: International Society of Urological Pathology Gleason Grade Group


name: Protocol-Specified Withdrawal Criterion Met


name: Intrasurgical Site Route of Administration


name: Clinical Outcomes Assessment Concept of Interest


name: Clinical Outcomes Assessment Context of Use


name: Exploratory Investigational New Drug Study


name: FDA Clinical Outcome Assessment Qualification


name: International Marketing Authorization Birth Date


name: Medicines And Healthcare Products Regulatory Agency


name: Patient-Reported Outcome Item Generation


name: Regulated Clinical Research and Information Management


name: Hyperfractionated Accelerated Radiation Delivered with Integrated Neck Surgery


name: CTRP Molecular Genetic Biomarker Terminology


name: Methionine Aminopeptidase 2 Inhibitor M8891


name: Transrectal Ultrasonography Guided Biopsy


name: Since First Time Questionnaire Was Answered Question


name: Minimally Invasive Interval Debulking Surgery


name: Mediastinal Malignant Germ Cell Tumor Stage


name: Supplemental Qualifiers Tabulation Dataset


name: Worst Nausea Past 24 Hours Rating Question


name: Undesirable Sedation Troubles Past 24 Hours Rating Question


name: Undesirable Appetite Increase Past 24 Hours Rating Question


name: CDISC Protocol Study Purpose Response Terminology


name: CDISC Protocol Subject Allocation Response Terminology


name: CDISC Protocol Randomization Type Response Terminology


name: Observed Medical Device Type Not Present In Intended Location Type


name: Associated Persons Laboratory Test Results Domain


name: Associated Persons Medical History Domain


name: Associated Persons Questionnaires Domain


name: Relationship between Associated Persons and Subjects Domain


name: Associated Persons Reproductive System Findings Domain


name: Adverse Events Supplemental Qualifiers Dataset


name: Procedure Agents Supplemental Qualifiers Dataset


name: Biospecimen Events Supplemental Qualifiers Dataset


name: Biospecimen Findings Supplemental Qualifiers Dataset


name: Body Weight Supplemental Qualifiers Dataset


name: Clinical Events Supplemental Qualifiers Dataset


name: Clinical Observations Supplemental Qualifiers Dataset


name: Concomitant and Prior Medications Supplemental Qualifiers Dataset


name: Comments Supplemental Qualifiers Dataset


name: Cardiovascular System Findings Supplemental Qualifiers Dataset


name: Drug Accountability Supplemental Qualifiers Dataset


name: Death Details (human clinical trials) Supplemental Qualifiers Dataset


name: Device Events Supplemental Qualifiers Dataset


name: Device Identifiers Supplemental Qualifiers Dataset


name: Demographics Supplemental Qualifiers Dataset


name: Device Properties Supplemental Qualifiers Dataset


name: Device Subject Relationships Supplemental Qualifiers Dataset


name: Disposition Supplemental Qualifiers Dataset


name: Device Tracking and Disposition Supplemental Qualifiers Dataset


name: Device In-Use Supplemental Qualifiers Dataset


name: Protocol Deviations Supplemental Qualifiers Dataset


name: Device Exposure Supplemental Qualifiers Dataset


name: Exposure as Collected Supplemental Qualifiers Dataset


name: ECG Test Results Supplemental Qualifiers Dataset


name: Exposure Supplemental Qualifiers Dataset


name: Findings About Events or Interventions Supplemental Qualifiers Dataset


name: Fetal Measurements Supplemental Qualifiers Dataset


name: Food and Water Consumption Supplemental Qualifiers Dataset


name: Fetal Pathology Findings Supplemental Qualifiers Dataset


name: Healthcare Encounters Supplemental Qualifiers Dataset


name: Implantation Classification Supplemental Qualifiers Dataset


name: Inclusion/Exclusion Criteria Not Met Supplemental Qualifiers Dataset


name: Immunogenicity Specimen Assessments Supplemental Qualifiers Dataset


name: Laboratory Test Results Supplemental Qualifiers Dataset


name: Macroscopic Findings Supplemental Qualifiers Dataset


name: Microbiology Specimen Supplemental Qualifiers Dataset


name: Medical History Supplemental Qualifiers Dataset


name: Microscopic Findings Supplemental Qualifiers Dataset